Eagle Pharmaceuticals, Inc. Contracts & Agreements

75 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter, dated November 8, 2024, between Christopher Krawtschuk and the Company
Eagle Pharmaceuticals, Inc.
2024
Third Amendment to Third Amended and Restated Credit Agreement, among Eagle Pharmaceuticals, Inc., as borrower, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders...
Eagle Pharmaceuticals, Inc.
2024
Separation Agreement dated March 8, 2024
Separation Agreements
Eagle Pharmaceuticals, Inc.
2024
Offer Letter dated March 8, 2024
Eagle Pharmaceuticals, Inc.
2024
Second Amendment to Third Amended and Restated Credit Agreement, among Eagle Pharmaceuticals, Inc., as borrower, JPMorgan Chase Bank, N.A., as administrative agent, and the...
Credit Agreements
Eagle Pharmaceuticals, Inc.
2024
Limited Waiver and First Amendment to Third Amended and Restated Credit Agreement, among Eagle Pharmaceuticals, Inc., as borrower, JPMorgan Chase Bank, N.A., as administrative...
Credit Agreements
Eagle Pharmaceuticals, Inc.
2024
Offer Letter, by and between the Company and Michael Graves, dated December 21, 2023
Eagle Pharmaceuticals, Inc.
2023
Separation Agreement dated November 27, 2023
Separation Agreements
Eagle Pharmaceuticals, Inc.
2023
Settlement Agreement, by and between the Registrant, Teva Pharmaceuticals International GmbH, Cephalon, LLC, Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc., dated...
Settlement Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2023
Amendment to Development and Licensing Agreement, by and between the Company and Robert One, LLC, dated December 9, 2022
Development Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
2022
Amended and Restated Severance Benefit Plan, effective as of December 9, 2022
Severance Agreements
Eagle Pharmaceuticals, Inc.
2022
Settlement and License Agreement, by and between Teva Pharmaceuticals International GmbH
Settlement Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2022
Guaranty Agreement to Loan Agreement, by and among the Registrant, Acacia Pharma Limited and Cosmo Technologies Ltd., dated June 9, 2022
Loan Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2022
Securities Purchase Agreement, by and between the Registrant and Enalare Therapeutics Inc., dated August 8, 2022
Purchase Agreements
Eagle Pharmaceuticals, Inc.
2022
Security Purchase Option Agreement, by and between the Registrant, Enalare Therapeutics Inc. and the other parties thereto, dated August 8, 2022
Purchase Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2022
Announcement, dated March 28, 2022
Eagle Pharmaceuticals, Inc.
2022
Co-operation Agreement, dated March 27, 2022, by and between Eagle Pharmaceuticals, Inc. and Acacia Pharma Group plc
Cooperation Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2022
Form of Shareholder Undertaking
Shareholders Agreements
Eagle Pharmaceuticals, Inc.
2022
Form of Director Undertaking
Eagle Pharmaceuticals, Inc.
2022
Lock-up Agreement, dated March 27, 2022, by and between Eagle Pharmaceuticals, Inc. and Cosmo Pharmaceuticals N.V
Eagle Pharmaceuticals, Inc.
2022
Form of Shareholder Lock-up Agreement
Shareholders Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2022
License Agreement, dated as of August 19, 2021, between the Registrant and Combioxin SA
License Agreements
Eagle Pharmaceuticals, Inc.
2021
License Agreement, dated as of August 6, 2021, between the Registrant and AOP Orphan Pharmaceuticals GmbH
License Agreements
Eagle Pharmaceuticals, Inc.
2021
Form of Performance Stock Unit Grant Package (2014 Equity Incentive Plan)
Bonus & Incentive Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
2021
Form of Performance Stock Unit Grant Package (2014 Equity Incentive Plan)
Bonus & Incentive Agreements
Eagle Pharmaceuticals, Inc.
2021
Consulting Agreement between
Consulting Agreements
Eagle Pharmaceuticals, Inc.
2020
Co-Promotion Agreement, dated January 7, 2020, between the Registrant and Tyme Technologies Inc
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2020
Co-Promotion Agreement with Tyme Technologies, Inc., dated January 7, 2020
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2020
Settlement Agreement, by and between the Registrant and Eli Lilly and Company, dated December 13, 2019
Settlement Agreements
Eagle Pharmaceuticals, Inc.
2020
Fifth Amendment to Lease Agreement between the Registrant and CAPSTONE TICE BLVD LLC. dated as of August 8, 2019
Lease Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
2020
Description of securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
Eagle Pharmaceuticals, Inc.
Biotechnology
2020
Securities Purchase Agreement, dated January 7, 2020, between the Company and Tyme
Purchase Agreements
Eagle Pharmaceuticals, Inc.
2020
Eagle Pharmaceuticals, Inc. Amended and Restated Severance Benefit Plan
Severance Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
NJ
2019
Fourth Amendment to the Exclusive License Agreement, dated April 12, 2019, by and between Eagle Pharmaceuticals, Inc., a Delaware corporation and Teva Pharmaceuticals...
License Agreements
Eagle Pharmaceuticals, Inc.
2019
Separation Agreement by and between the Registrant and Steven L. Krill, dated February 19, 201
Separation Agreements
Eagle Pharmaceuticals, Inc.
2018
Form of Restricted Stock Unit Grant Package (2014 Equity Incentive Plan)
Bonus & Incentive Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
2018
Form of Performance Stock Unit Grant Package (2014 Equity Incentive Plan)
Bonus & Incentive Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
2018
Amendment No. 1 to Stock Purchase Agreement, dated as of February 8, 2018
Stock Agreements
Eagle Pharmaceuticals, Inc.
2018
Separation Agreement dated January 24, 2018
Separation Agreements
Eagle Pharmaceuticals, Inc.
2018
Product Collaboration and License Agreement, by and between the Registrant and SymBio Pharmaceuticals Limited, effective as of September 19, 2017
Collaboration Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
NY
2017
[SIGNATURE PAGE FOLLOWS]
Eagle Pharmaceuticals, Inc.
Biotechnology
NY
2017
CREDIT AGREEMENT dated as of January 26, 2017 among EAGLE PHARMACEUTICALS, INC. The Lenders Party Hereto and JPMORGAN CHASE BANK, N.A. as Administrative Agent JPMORGAN CHASE BANK,...
Credit Agreements
Eagle Pharmaceuticals, Inc.
2017
STOCK PURCHASE AGREEMENT BY AND AMONG EAGLE PHARMACEUTICALS, INC. (as Buyer), ARSIA THERAPEUTICS, LLC (the Seller), ARSIA THERAPEUTICS, INC. (the Company), AMY SCHULMAN (solely in...
Stock Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2016
CO-PROMOTION AGREEMENT
Eagle Pharmaceuticals, Inc.
2016
LICENSE AGREEMENT
License Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
NY
2016
EAGLE PHARMACEUTICALS, INC. STOCK OPTION GRANT NOTICE (2014 EQUITY INCENTIVE PLAN)
Bonus & Incentive Agreements
Eagle Pharmaceuticals, Inc.
2015
* * *
Eagle Pharmaceuticals, Inc.
Biotechnology
2015
AMENDMENT TO THE EAGLE PHARMACEUTICALS, INC. 2007 INCENTIVE COMPENSATION PLAN
Bonus & Incentive Agreements
Eagle Pharmaceuticals, Inc.
2015
AMENDMENT NO. 2 TO DEVELOPMENT AND LICENSING AGREEMENT
Development Agreements
Eagle Pharmaceuticals, Inc.
2015
AMENDMENT NO. 4 TO DEVELOPMENT AND LICENSING AGREEMENT
Development Agreements
Eagle Pharmaceuticals, Inc.
2015
APPENDIX A EAGLE PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: NOVEMBER 21, 2013 APPROVED BY THE STOCKHOLDERS: JANUARY 26, 2014 IPO DATE:...
Bonus & Incentive Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2015
EAGLE PHARMACEUTICALS, INC. OFFICER SEVERANCE BENEFIT PLAN APPROVED BY THE BOARD OF DIRECTORS: AUGUST 4, 2015
Severance Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
2015
SETTLEMENT AND LICENSE AGREEMENT
Settlement Agreements
Eagle Pharmaceuticals, Inc.
2015
EXCLUSIVE LICENSE AGREEMENT between EAGLE PHARMACEUTICALS, INC. and CEPHALON, INC. dated February 13, 2015
License Agreements
Eagle Pharmaceuticals, Inc.
2015
1,320,276 Shares Eagle Pharmaceuticals, Inc. Common Stock PURCHASE AGREEMENT
Stock Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
NY
2015
[ ] Shares Eagle Pharmaceuticals, Inc. Common Stock PURCHASE AGREEMENT
Stock Agreements
Eagle Pharmaceuticals, Inc.
2014
EMPLOYMENT AGREEMENT
Employment Agreements
Eagle Pharmaceuticals, Inc.
2014
EAGLE PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: , 201 APPROVED BY THE STOCKHOLDERS: , 201 IPO DATE: , 201
Bonus & Incentive Agreements
Eagle Pharmaceuticals, Inc.
2014
EAGLE PHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: , 201 APPROVED BY THE STOCKHOLDERS: , 201
Stock Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
2014
EAGLE PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
Compensation Agreements
Eagle Pharmaceuticals, Inc.
2014
SHORT FORM LEASE Between MACK-CALI CHESTNUT RIDGE L.L.C., as Landlord, and EAGLE PHARMACEUTICALS, INC., as Tenant Building: 50 Tice Boulevard, Woodcliff Lake, New Jersey
Lease Agreements
Eagle Pharmaceuticals, Inc.
2013
EAGLE PHARMACEUTICALS, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2013
EAGLE PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreements
Eagle Pharmaceuticals, Inc.
2013
EAGLE PHARMACEUTICALS, INC. 2007 INCENTIVE COMPENSATION PLAN
Bonus & Incentive Agreements
Eagle Pharmaceuticals, Inc.
2013
David Riggs
Eagle Pharmaceuticals, Inc.
Biotechnology
2013
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
NY
2013
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
Eagle Pharmaceuticals, Inc.
2013
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
Eagle Pharmaceuticals, Inc.
2013
SUPPLY AND DISTRIBUTION AGREEMENT
Supply Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
NY
2013
DATED 14 DECEMBER 2012 AGREEMENT FOR THE SUPPLY OF ARGATROBAN AND TOPOTECAN between CIPLA LIMTED and EAGLE PHARMACEUTICALS, INC.
Supply Agreements
Eagle Pharmaceuticals, Inc.
2013
SUPPLY AGREEMENT
Supply Agreements
Eagle Pharmaceuticals, Inc.
2013
LICENSE AND DEVELOPMENT AGREEMENT
License Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
NY
2013
LICENSE AND SUBLICENSE AGREEMENT BETWEEN LYOTROPIC THERAPEUTICS, INC. AND EAGLE PHARMACEUTICALS, INC.
License Agreements
Eagle Pharmaceuticals, Inc.
2013
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
Eagle Pharmaceuticals, Inc.
2013
Rights Agreement, dated as of October 30, 2024 between Eagle Pharmaceuticals, Inc. and Equiniti Trust Company, LLC., which includes the form of Certificate of Designation as...
Eagle Pharmaceuticals, Inc.
2024